Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 89
  • 14
  • 171
  • 696
  • 448
  • 14
  • 31
  • 1
  • 4
  • 648

Found 698 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 A Phase 2B Prospective  Randomized  Double-blinded  Placebo-controlled Clinical Study Demonstrating the Efficacy and Safety of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection
1 years - 99 years
All genders
Phase 2
Rebiotix Incs RBX2660 (microbiota suspension) is an intestinal microbial suspension intended to treat recurrent Clostridium difficile infection (CDI). RBX2660 is administered via enema and is for rectal use only. Administration of similar products, commonly known as fecal transplants (FT), have documented significant clinical evidence of safe and effective use for …
 Estudio aleatorizado, doble ciego, paralelo y controlado con placebo sobre la eficacia, la seguridad y la tolerabilidad de dupilumab en pacientes adultos con esofagitis eosinofílica activa
1 years - 99 years
All genders
Phase 2
Este es un estudio de prueba de concepto multicéntrico, aleatorizado, doble ciego, controlado con placebo, de 2 brazos, de grupos paralelos. El objetivo principal de este estudio es evaluar el efecto de dupilumab en el alivio de los síntomas clínicos de la EoE y la reducción de la inflamación esofágica …
21 years - 70 years
Accepts healthy volunteer
All genders
The Serenity Study is a voluntary research study that will investigate different approaches to stress management in order to help lower blood pressure. You may be eligible to participate if you: have blood pressure in the pre-hypertensive range (systolic BP 120-139 or diastolic BP 80-89), are a healthy adult between …
 FES PET/CT in Endocrine Refractory Breast Cancer
18 years - 99 years
Female
Phase 3
Patients with recurrent or metastatic ER+ breast cancer, who have failed prior endocrine therapy may be eligible for this study.  Patients may participate in this study, if they are at least 18 years of age, most participants will be receiving care at the clinical practices of the University of Pennsylvania. …
 Radiation Oncology Registry
18 years - 99 years
All genders
You are being asked to participate in the Radiation Oncology Registry. Participation in this study requires no additional obligations on your part; your participation means you are granting permission for your doctors to extract information from your medical chart and use this data for research purposes. Should any findings from …
 Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT® (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder
21 years - 100 years
All genders
Phase 2
Alternating phone and in-clinic visits for medical management (MM), laboratory tests, and physical exams, to assess drug compliance, to complete additional questionnaires, and to provide counseling (via “Take Control” videos) over 29 weeks.
 The Effect of Potassium Nitrate [KNO3] on Exercise Capacity in Heart Failure Patients.
18 years - 90 years
All genders
Phase 2
This study will test whether Potassium Nitrate (KNO3) will improve how people with HFpEF [Diastolic Heart Failure] can exercise. In HFpEF, patients are limited in their ability to do all the things they want to do, and exercise as much as they would like, due to becoming tired and short …
 METAMORPH
99 years or below
All genders
This is a cohort study of women with suspected or confirmed recurrent breast cancer, with accessible tumor by standard clinical biopsy, prior to starting a new therapy for recurrent metastatic disease. Study participants will be ascertained from the population of all persons greater than eighteen years of age receiving care …
 North American Registry for Care and Research in MS - NARCRMS
18 years - 50 years
All genders
NARCRMS is a national database that collects patient and physician-based information on MS and will bring together information and data collected in multiple registries and databases across the U.S. and Canada. We expect that data collected consistently over long periods of time, when carefully studied, will 1) produce new clues …
381 - 390 of 698